Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Preoperative Exercise × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 3 Colorectal Neoplasms 2 Breast Neoplasms 2 Postoperative Complications 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Disease 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 42 Cyclophosphamide 24 Bevacizumab 22 Blood Specimen Collection 19 Nivolumab 17 Paclitaxel 13 Carboplatin 13 Doxorubicin 12 atezolizumab 11 Pemetrexed 11 Gemcitabine 11 fludarabine 10 Rituximab 10 Oxaliplatin 10 Fluorouracil 10 Leucovorin 9 Temozolomide 8 Surveys and Questionnaires 8 Standard of Care 8 Magnetic Resonance Spectroscopy 8 Interviews as Topic 8 Exercise 8 Cisplatin 8 Cetuximab 8 Biopsy 8 durvalumab 7 Prednisone 7 Docetaxel 7 Dexamethasone 7 130-nm albumin-bound paclitaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07464457 2026-03-11

NEOPRO-SIT

University Hospital Muenster

Phase NA Recruiting

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡